Company news
Enliven Therapeutics, Inc. news in 2026
Enliven Therapeutics, Inc.'s news releases, calls and decks from 2026, newest first.
Enliven Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Business Update
November 5, 2026
Enliven Therapeutics Appoints Kristine Ball to Board of Directors Ahead of Planned Phase 3 Trial Initiation this Year
October 14, 2026
Enliven Therapeutics Announces FDA Alignment on ENABLE-2 Phase 3 Trial Design for Relcobatinib (ELVN-001) in Previously Treated Chronic Myeloid Leukemia
October 6, 2026
Enliven Therapeutics Announces Oral and Poster Presentations at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting
August 31, 2026
Elevar Therapeutics Receives FDA Complete Response Letter for Combination of Rivoceranib and Camrelizumab as a First-line Treatment for Unresectable or Metastatic Hepatocellular Carcinoma
July 10, 2026
Enliven Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares
June 15, 2026
Enliven Therapeutics Announces Updated Positive Phase 1 Clinical Data and Alignment with FDA on Key Phase 3 Trial Design Components
June 11, 2026
Enliven Therapeutics to Host Webcast Conference Call to Discuss Phase 1 ELVN-001 Clinical Data Being Presented at EHA 2026 Congress
June 3, 2026
Enliven Therapeutics Announces Oral Presentation at the EHA 2026 Congress Featuring Additional Positive Phase 1 Clinical Trial Data for ELVN-001 in CML
May 12, 2026
Enliven Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
March 3, 2026
Enliven Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference
February 25, 2026
Enliven Reports Positive Initial Phase 1b Data for ELVN-001 in CML and Outlines 2026 Clinical Milestones
January 7, 2026
Enliven Therapeutics Bolsters Board to Prepare for Next Phase of Development
January 6, 2026
Decks in 2026
- Investor Presentation (October 2026)
Investor deck · 29 slides · Oct 5, 2026
- EHA 2026 Congress
Conference · 33 slides · Jun 11, 2026